Shang Hao, Zeng Jian-Ping, Wang Si-Yuan, Xiao Ying, Yang Jiang-Hui, Yu Shao-Qing, Liu Xiang-Chen, Jiang Nan, Shi Xia-Li, Jin Shuo
Department of Hepatopancreatobiliary Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102200, China.
Department of Pathology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102200, China.
World J Gastroenterol. 2020 Dec 14;26(46):7312-7324. doi: 10.3748/wjg.v26.i46.7312.
Extrahepatic biliary duct injury (BDI) remains a complicated issue for surgeons. Although several approaches have been explored to address this problem, the high incidence of complications affects postoperative recovery. As a nonimmunogenic scaffold, an animal-derived artificial bile duct (ada-BD) could replace the defect, providing good physiological conditions for the regeneration of autologous bile duct structures without changing the original anatomical and physiologic conditions.
To evaluate the long-term feasibility of a novel heterogenous ada-BD for treating extrahepatic BDI in pigs.
Eight pigs were randomly divided into two groups in the study. The animal injury model was developed with an approximately 2 cm segmental defect of various parts of the common bile duct (CBD) for all pigs. A 2 cm long novel heterogenous animal-derived bile duct was used to repair this segmental defect (group A, ada-BD-to-duodenum anastomosis to repair the distal CBD defect; group B, ada-BD-to-CBD anastomosis to repair the intermedial CBD defect). The endpoint for observation was 6 mo (group A) and 12 mo (group B) after the operation. Liver function was regularly tested. Animals were euthanized at the above endpoints. Histological analysis was carried out to assess the efficacy of the repair.
The median operative time was 2.45 h (2-3 h), with a median anastomosis time of 60.5 min (55-73 min). All experimental animals survived until the endpoints for observation. The liver function was almost regular. Histologic analysis indicated a marked biliary epithelial layer covering the neo-bile duct and regeneration of the submucosal connective tissue and smooth muscle without significant signs of immune rejection. In comparison, the submucosal connective tissue was more regular and thicker in group B than in group A, and there was superior integrity of the regeneration of the biliary epithelial layer. Despite the advantages of the regeneration of the bile duct smooth muscle observed in group A, the effect on the patency of the ada-BD grafts in group B was not confirmed by macroscopic assessment and cholangiography.
This approach appears to be feasible for repairing a CBD defect with an ada-BD. A large sample study is needed to confirm the durability and safety of these preliminary results.
肝外胆管损伤(BDI)对外科医生来说仍是一个复杂的问题。尽管已经探索了多种方法来解决这一问题,但并发症的高发生率影响术后恢复。作为一种非免疫原性支架,动物源人工胆管(ada-BD)可以替代缺损部位,为自体胆管结构的再生提供良好的生理条件,同时不改变原有的解剖和生理状况。
评估一种新型异种ada-BD治疗猪肝外BDI的长期可行性。
本研究将8头猪随机分为两组。所有猪均建立胆总管(CBD)各部位约2cm节段性缺损的动物损伤模型。使用一条2cm长的新型异种动物源胆管修复该节段性缺损(A组,ada-BD与十二指肠吻合以修复远端CBD缺损;B组,ada-BD与CBD吻合以修复中间段CBD缺损)。观察终点为术后6个月(A组)和12个月(B组)。定期检测肝功能。在上述终点对动物实施安乐死。进行组织学分析以评估修复效果。
中位手术时间为2.45小时(2 - 3小时),中位吻合时间为60.5分钟(55 - 73分钟)。所有实验动物均存活至观察终点。肝功能基本正常。组织学分析表明,新胆管上有明显的胆管上皮层覆盖,黏膜下结缔组织和平滑肌再生,无明显免疫排斥迹象。相比之下,B组黏膜下结缔组织比A组更规则、更厚,胆管上皮层再生的完整性更好。尽管在A组观察到胆管平滑肌再生有优势,但宏观评估和胆管造影未证实B组ada-BD移植物的通畅效果。
这种方法用ada-BD修复CBD缺损似乎是可行的。需要进行大样本研究来证实这些初步结果的耐久性和安全性。